Shelter Pharma Ltd — Updates, 10-04-2025: Company Update

Shelter Pharma Limited has submitted a certificate related to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations for the quarter ended 31st March 2025. The company confirms that all shares are held in demat form, with no requests for rematerialisation or dematerialisation during this period. This clarity on shareholding structure underscores the company's commitment to maintaining transparent operations.

From an investor perspective, this could foster a positive outlook, reflecting stability in share administration and potentially enhancing shareholder confidence in the company’s governance practices.